NVN Liquidation Inc (LTS:0A4P)
$ 8.075 0 (0%) Market Cap: 22,000.00 Enterprise Value: -8.67 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 26/100

Novan Inc at JMP Securities Life Science Conference Transcript

Jun 20, 2019 / 01:30PM GMT
Don Ellis
JMP Securities - Analyst

Ready for our next presentation -- Novan. From the Company today we have Chief Executive Officer, Kelly Martin, and Cole Ikkala, the Director of IR and Business Development.

Cole Ikkala
Novan, Inc. - Director of IR & Business Development

All right, thank you, Don, and good morning everybody in the room and on the webcast. I will provide a 15- to 20-minute update on Novan. It's a point-in-time update of some recent progress and focus on the near-term. And then we will turn it over to Kelly Martin, our CEO, for Q&A and fireside chat with Don.

The framework in the agenda today is to focus on three things: balance sheet and financial picture; our near-term focus, being the execution of our Phase 3 molluscum program; and finally, some additional business model updates and advancements that we've recently announced and we'll be focused on in the near term.

This presentation will have forward-looking statements. Obviously forward-looking statements are subject to a number of risks and uncertainties. For

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot